✦ LIBER ✦

SRL172 (killed Mycobacterium vaccae) may augment the efficacy of trastuzumab in metastatic breast cancer patients

✍ Scribed by Kadri Altundag; Ali-Seyed Mohamed; Ozden Altundag; Yavuz Selim Silay; Esra Gunduz; Kadir Demircan

Book ID: 116742352
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 235 KB
Volume: 64
Category: Article
ISSN: 0306-9877
DOI: 10.1016/j.mehy.2004.07.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O-109 Improved quality of life with the

O-109 Improved quality of life with the addition of SRL172 (killed mycobacterium vaccae) to standard chemotherapy in patients with advanced non-small cell lung cancer: Phase III results

✍ O'Brien, Mary E.R.; Anderson, H.; Kaukel, E.; O'Byrne, K.; Pawlicki, M.; von Paw 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 189 KB

635 A study of SRL 172 (mycobacterium va

635 A study of SRL 172 (mycobacterium vaccae) as the first component of a tumour vaccine with immunological changes and clinical activity in patients with lung cancer

✍ O'Brien, M.E.R.; Bromelow, K.; Prendiville, J.; Rees, C.; Hill, M.; Stanford, J. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Her-2/neu and EGFR tyrosine kinase activ

Her-2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab-based therapy in patients with metastatic breast cancer

✍ Gernot Hudelist; Wolfgang J. Köstler; Klaus Czerwenka; Ernst Kubista; Johannes A 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 372 KB 👁 2 views

## Abstract Her‐2/__neu__ overexpression in human breast cancer leads to an aggressive biological behavior and poor prognosis. Although the anti‐Her‐2/__neu__ antibody trastuzumab (Herceptin®) has become a valuable therapeutic option for patients with Her‐2/__neu__‐overexpressing breast cancer, man

Phase II evaluation of the efficacy and

Phase II evaluation of the efficacy and safety of trastuzumab plus pertuzumab therapy in patients with HER2-positive metastatic breast cancer that had progressed during trastuzumab treatment

✍ J. Cortes; K. Gelmon; P. Fumoleau; A. Wardley; S. Verma; P.F. Conte; L. Gianni; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB

188 Efficacy and Safety of Lapatinib Tre

188 Efficacy and Safety of Lapatinib Treatment in Trastuzumab Pretreated Patients with HER2 Positive Metastatic Breast Cancer – An Analysis of IntERB Registry in the Czech Republic

✍ P. Grell; V. Kandrnal; Z. Bortlicek; R. Vyzula 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 72 KB

464 Efficacy and toxicity of docetaxel o

464 Efficacy and toxicity of docetaxel or cisplatin chemotherapy in combination with trastuzumab in the treatment of patients with chemotherapy pre-treated HER-2/neu overexpressed metastatic breast cancer

✍ B. Bauer-Kosinska; I. Lemanska; I. Glogowska; R. Sienkiewicz; T. Pienkowski 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 156 KB